Matches in SemOpenAlex for { <https://semopenalex.org/work/W137447747> ?p ?o ?g. }
- W137447747 abstract "Abstract Fetal hemoglobin (HbF) production induced by hydroxyurea is the mainstay of treatment for sickle cell anemia (SCA). Increased HbF production correlates with a higher number of HbF-containing red blood cells (RBCs) called F-cells. Successful treatment with hydroxyurea is associated with an increased number of F-cells, less hemolysis, improvement of anemia, and decreased frequency of vaso-occlusive crises in SCA patients. Comparison of in vitro sickling among blood specimens from sickle mouse models and from patients with different HbF levels has provided compelling evidence that increasing the percentage of circulating F-cells is associated with improvement of hemolytic biomarkers. While it has been demonstrated that higher HbF content prolongs sickle RBC survival, there is only indirect evidence of the response to hypoxia of F-cells compared to non-F-cells. We investigated the influence of HbF content on sickling through our recently developed Sickle Imaging Flow Cytometry Assay (SIFCA). SIFCA allows simultaneous analysis of both expression of intracellular proteins and morphological features of each cell in a robust, reproducible, operator-independent sickling assay. Peripheral venous blood samples were collected upon written consent from adult SCA patients with a wide range of HbF percentages (HbF range 2.0-26.9%) (n=15, nine on hydroxyurea treatment). RBC pellets were used to prepare 1% suspensions that were subjected to deoxygenation for 2 hours at 2% oxygen. RBCs were then labeled for HbF using a standard protocol for F-cell quantitation and a minimum of 20,000 cells were analyzed by imaging flow cytometry (ImageStreamX Mk II, Amnis Corporation), allowing the correlation between shape change and intensity of HbF expression for each RBC. We confirmed previous observations using conventional flow cytometry that F-cell count percentages significantly correlate with mean HbF determined by HPLC (r2P=0.9700, 95% CI 0.9098-0.9902, P<0.0001). F-cell count by SIFCA correlated highly with conventional F-cell flow cytometry by an independent CLIA-certified facility (r2P =0.9976, 95% CI 0.9861-0.9996, P<0.0001). SIFCA morphological analysis showed that the percentage of non-F-cells sickling upon deoxygenation was significantly higher than among F-cells (17.75% [95% CI 12.5-23.00] vs. 12.41% [95% CI 8.67-16.15], P=0.0015), a 1.498-fold difference (95% CI 1.228-1.768). Image analysis also allowed us to identify the presence of F-cells that still sickle despite their high HbF content, as well as non-F-cells that are resistant to sickling (Figure 1). Transmission electron microscopy of F-cells enriched by fluorescence activated cell sorting confirmed that sickled F-cells contained hemoglobin S polymers. In summary, we have documented for the first time at the individual RBC level that human F-cells are less prone to sickle under hypoxia ex vivo than non-F-cells. This study also illustrates the power of imaging flow cytometry to characterize predisposition to sickling in populations of red blood cells from the same patient, and would be suitable for use as a supportive biomarker assay in clinical trials investigating the efficacy of novel HbF inducers and their anti-sickling effect in a single assay. While the finding that F-cells sickle less than non-F-cells is not unexpected, it seems surprising to us that the difference in hypoxia-induced sickling between F-cells and non-F-cells is so small. This finding emphasizes the need to characterize additional RBC features that render individual cells more susceptible or resistant to sickling. Identification of factors besides HbF that modulate sickle hemoglobin polymerization may help design novel therapies for hydroxyurea-resistant SCA patients.Figure 1Sample images showing non-F-cells (left column) and F-cells (right column) as they appear on imaging flow cytometry. Under hypoxic conditions, non-F-cells are expected to sickle (panel A), while F-cells are expected to maintain a round shape (panel B). Nevertheless, round erythrocytes can be found among non-F-cells (panel C), as well as typically sickled F-cells (panel D).Figure 1. Sample images showing non-F-cells (left column) and F-cells (right column) as they appear on imaging flow cytometry. Under hypoxic conditions, non-F-cells are expected to sickle (panel A), while F-cells are expected to maintain a round shape (panel B). Nevertheless, round erythrocytes can be found among non-F-cells (panel C), as well as typically sickled F-cells (panel D). Disclosures: No relevant conflicts of interest to declare." @default.
- W137447747 created "2016-06-24" @default.
- W137447747 creator A5001705210 @default.
- W137447747 creator A5007020077 @default.
- W137447747 creator A5010536631 @default.
- W137447747 creator A5022606690 @default.
- W137447747 creator A5029810560 @default.
- W137447747 creator A5047135844 @default.
- W137447747 creator A5052681436 @default.
- W137447747 creator A5053280802 @default.
- W137447747 creator A5066832003 @default.
- W137447747 creator A5077898822 @default.
- W137447747 creator A5081289293 @default.
- W137447747 date "2013-11-15" @default.
- W137447747 modified "2023-09-29" @default.
- W137447747 title "Imaging Flow Cytometry Documents Incomplete Resistance Of F-Cells To Hypoxia-Induced Sickling In Blood Samples From Patients With Sickle Cell Anemia" @default.
- W137447747 doi "https://doi.org/10.1182/blood.v122.21.183.183" @default.
- W137447747 hasPublicationYear "2013" @default.
- W137447747 type Work @default.
- W137447747 sameAs 137447747 @default.
- W137447747 citedByCount "0" @default.
- W137447747 crossrefType "journal-article" @default.
- W137447747 hasAuthorship W137447747A5001705210 @default.
- W137447747 hasAuthorship W137447747A5007020077 @default.
- W137447747 hasAuthorship W137447747A5010536631 @default.
- W137447747 hasAuthorship W137447747A5022606690 @default.
- W137447747 hasAuthorship W137447747A5029810560 @default.
- W137447747 hasAuthorship W137447747A5047135844 @default.
- W137447747 hasAuthorship W137447747A5052681436 @default.
- W137447747 hasAuthorship W137447747A5053280802 @default.
- W137447747 hasAuthorship W137447747A5066832003 @default.
- W137447747 hasAuthorship W137447747A5077898822 @default.
- W137447747 hasAuthorship W137447747A5081289293 @default.
- W137447747 hasConcept C126322002 @default.
- W137447747 hasConcept C1491633281 @default.
- W137447747 hasConcept C153911025 @default.
- W137447747 hasConcept C16685009 @default.
- W137447747 hasConcept C172680121 @default.
- W137447747 hasConcept C178790620 @default.
- W137447747 hasConcept C185592680 @default.
- W137447747 hasConcept C203014093 @default.
- W137447747 hasConcept C2776175824 @default.
- W137447747 hasConcept C2776317666 @default.
- W137447747 hasConcept C2776557347 @default.
- W137447747 hasConcept C2778248108 @default.
- W137447747 hasConcept C2778620579 @default.
- W137447747 hasConcept C2779234561 @default.
- W137447747 hasConcept C2779668550 @default.
- W137447747 hasConcept C2779902561 @default.
- W137447747 hasConcept C2780339063 @default.
- W137447747 hasConcept C540031477 @default.
- W137447747 hasConcept C54355233 @default.
- W137447747 hasConcept C553184892 @default.
- W137447747 hasConcept C55493867 @default.
- W137447747 hasConcept C71924100 @default.
- W137447747 hasConcept C7836513 @default.
- W137447747 hasConcept C86803240 @default.
- W137447747 hasConceptScore W137447747C126322002 @default.
- W137447747 hasConceptScore W137447747C1491633281 @default.
- W137447747 hasConceptScore W137447747C153911025 @default.
- W137447747 hasConceptScore W137447747C16685009 @default.
- W137447747 hasConceptScore W137447747C172680121 @default.
- W137447747 hasConceptScore W137447747C178790620 @default.
- W137447747 hasConceptScore W137447747C185592680 @default.
- W137447747 hasConceptScore W137447747C203014093 @default.
- W137447747 hasConceptScore W137447747C2776175824 @default.
- W137447747 hasConceptScore W137447747C2776317666 @default.
- W137447747 hasConceptScore W137447747C2776557347 @default.
- W137447747 hasConceptScore W137447747C2778248108 @default.
- W137447747 hasConceptScore W137447747C2778620579 @default.
- W137447747 hasConceptScore W137447747C2779234561 @default.
- W137447747 hasConceptScore W137447747C2779668550 @default.
- W137447747 hasConceptScore W137447747C2779902561 @default.
- W137447747 hasConceptScore W137447747C2780339063 @default.
- W137447747 hasConceptScore W137447747C540031477 @default.
- W137447747 hasConceptScore W137447747C54355233 @default.
- W137447747 hasConceptScore W137447747C553184892 @default.
- W137447747 hasConceptScore W137447747C55493867 @default.
- W137447747 hasConceptScore W137447747C71924100 @default.
- W137447747 hasConceptScore W137447747C7836513 @default.
- W137447747 hasConceptScore W137447747C86803240 @default.
- W137447747 hasLocation W1374477471 @default.
- W137447747 hasOpenAccess W137447747 @default.
- W137447747 hasPrimaryLocation W1374477471 @default.
- W137447747 hasRelatedWork W1531256486 @default.
- W137447747 hasRelatedWork W18598464 @default.
- W137447747 hasRelatedWork W2022368107 @default.
- W137447747 hasRelatedWork W2032422161 @default.
- W137447747 hasRelatedWork W2034628210 @default.
- W137447747 hasRelatedWork W2053960163 @default.
- W137447747 hasRelatedWork W2057896284 @default.
- W137447747 hasRelatedWork W2065540401 @default.
- W137447747 hasRelatedWork W2155090266 @default.
- W137447747 hasRelatedWork W2161933079 @default.
- W137447747 hasRelatedWork W2229661026 @default.
- W137447747 hasRelatedWork W2268927030 @default.
- W137447747 hasRelatedWork W2407604932 @default.
- W137447747 hasRelatedWork W2433440883 @default.
- W137447747 hasRelatedWork W2605742629 @default.
- W137447747 hasRelatedWork W2909253192 @default.